Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to chemotherapy. This paper reviews various CTCs and ct DNA...
Saved in:
| Main Authors: | Felix Wong, Bee Luan Khoo, Karen Kar Loen Chan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-06-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/50/6/10.31083/j.ceog5006132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid Biopsy-Derived Tumor Biomarkers for Clinical Applications in Glioblastoma
by: Bruna Pereira de Lima, et al.
Published: (2025-05-01) -
Liquid biopsies in cancer
by: Hang Yin, et al.
Published: (2025-03-01) -
Liquid biopsy: paving a new avenue for cancer research
by: Keerthi Kurma, et al.
Published: (2024-12-01) -
The importance of circulating tumor products as „liquid biopsies” in colorectal cancer
by: Alina Miscoci, et al.
Published: (2018-04-01) -
Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective
by: Sridhar Mishra, et al.
Published: (2024-12-01)